 | • レポートコード：MRC2-11QY12666 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は転移性大腸癌手術のグローバル市場について調査・分析したレポートです。種類別（腫瘍切除、門脈塞栓術）市場規模、用途別（病院、クリニック、がん研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別転移性大腸癌手術の競争状況、市場シェア ・世界の転移性大腸癌手術市場：種類別市場規模 2015年-2020年（腫瘍切除、門脈塞栓術） ・世界の転移性大腸癌手術市場：種類別市場規模予測 2021年-2026年（腫瘍切除、門脈塞栓術） ・世界の転移性大腸癌手術市場：用途別市場規模 2015年-2020年（病院、クリニック、がん研究センター） ・世界の転移性大腸癌手術市場：用途別市場規模予測 2021年-2026年（病院、クリニック、がん研究センター） ・北米の転移性大腸癌手術市場分析：米国、カナダ ・ヨーロッパの転移性大腸癌手術市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの転移性大腸癌手術市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の転移性大腸癌手術市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの転移性大腸癌手術市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Roche、Eli Lilly、Pfizer、Novartis、Amgen、Taiho Oncology、Genentech、EMD Serono、Suzhou Zelgen Biopharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
Market Analysis and Insights: Global Metastatic Colorectal Cancer Surgery Market
The global Metastatic Colorectal Cancer Surgery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Metastatic Colorectal Cancer Surgery Scope and Market Size
Metastatic Colorectal Cancer Surgery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Colorectal Cancer Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Market segment by Type, the product can be split into
Tumor Resection
Portal Vein Embolization
Market segment by Application, split into
Hospitals
Clinics
Cancer Research Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metastatic Colorectal Cancer Surgery Revenue
1.4 Market by Type
1.4.1 Global Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tumor Resection
1.4.3 Portal Vein Embolization
1.5 Market by Application
1.5.1 Global Metastatic Colorectal Cancer Surgery Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Research Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Colorectal Cancer Surgery Market Perspective (2015-2026)
2.2 Global Metastatic Colorectal Cancer Surgery Growth Trends by Regions
2.2.1 Metastatic Colorectal Cancer Surgery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Metastatic Colorectal Cancer Surgery Historic Market Share by Regions (2015-2020)
2.2.3 Metastatic Colorectal Cancer Surgery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Metastatic Colorectal Cancer Surgery Market Growth Strategy
2.3.6 Primary Interviews with Key Metastatic Colorectal Cancer Surgery Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Colorectal Cancer Surgery Players by Market Size
3.1.1 Global Top Metastatic Colorectal Cancer Surgery Players by Revenue (2015-2020)
3.1.2 Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Players (2015-2020)
3.1.3 Global Metastatic Colorectal Cancer Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio
3.2.1 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Surgery Revenue in 2019
3.3 Metastatic Colorectal Cancer Surgery Key Players Head office and Area Served
3.4 Key Players Metastatic Colorectal Cancer Surgery Product Solution and Service
3.5 Date of Enter into Metastatic Colorectal Cancer Surgery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Type (2015-2020)
4.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
5.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Metastatic Colorectal Cancer Surgery Market Size (2015-2020)
6.2 Metastatic Colorectal Cancer Surgery Key Players in North America (2019-2020)
6.3 North America Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
6.4 North America Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
7 Europe
7.1 Europe Metastatic Colorectal Cancer Surgery Market Size (2015-2020)
7.2 Metastatic Colorectal Cancer Surgery Key Players in Europe (2019-2020)
7.3 Europe Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
7.4 Europe Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
8 China
8.1 China Metastatic Colorectal Cancer Surgery Market Size (2015-2020)
8.2 Metastatic Colorectal Cancer Surgery Key Players in China (2019-2020)
8.3 China Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
8.4 China Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
9 Japan
9.1 Japan Metastatic Colorectal Cancer Surgery Market Size (2015-2020)
9.2 Metastatic Colorectal Cancer Surgery Key Players in Japan (2019-2020)
9.3 Japan Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
9.4 Japan Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Metastatic Colorectal Cancer Surgery Market Size (2015-2020)
10.2 Metastatic Colorectal Cancer Surgery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
10.4 Southeast Asia Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
11 India
11.1 India Metastatic Colorectal Cancer Surgery Market Size (2015-2020)
11.2 Metastatic Colorectal Cancer Surgery Key Players in India (2019-2020)
11.3 India Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
11.4 India Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Metastatic Colorectal Cancer Surgery Market Size (2015-2020)
12.2 Metastatic Colorectal Cancer Surgery Key Players in Central & South America (2019-2020)
12.3 Central & South America Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
12.4 Central & South America Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Metastatic Colorectal Cancer Surgery Introduction
13.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Metastatic Colorectal Cancer Surgery Introduction
13.2.4 Roche Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Metastatic Colorectal Cancer Surgery Introduction
13.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Metastatic Colorectal Cancer Surgery Introduction
13.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Metastatic Colorectal Cancer Surgery Introduction
13.5.4 Novartis Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Metastatic Colorectal Cancer Surgery Introduction
13.6.4 Amgen Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Taiho Oncology
13.7.1 Taiho Oncology Company Details
13.7.2 Taiho Oncology Business Overview
13.7.3 Taiho Oncology Metastatic Colorectal Cancer Surgery Introduction
13.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
13.7.5 Taiho Oncology Recent Development
13.8 Genentech
13.8.1 Genentech Company Details
13.8.2 Genentech Business Overview
13.8.3 Genentech Metastatic Colorectal Cancer Surgery Introduction
13.8.4 Genentech Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
13.8.5 Genentech Recent Development
13.9 EMD Serono
13.9.1 EMD Serono Company Details
13.9.2 EMD Serono Business Overview
13.9.3 EMD Serono Metastatic Colorectal Cancer Surgery Introduction
13.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
13.9.5 EMD Serono Recent Development
13.10 Suzhou Zelgen Biopharmaceuticals
13.10.1 Suzhou Zelgen Biopharmaceuticals Company Details
13.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
13.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Introduction
13.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
13.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Metastatic Colorectal Cancer Surgery Key Market Segments
Table 2. Key Players Covered: Ranking by Metastatic Colorectal Cancer Surgery Revenue
Table 3. Ranking of Global Top Metastatic Colorectal Cancer Surgery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tumor Resection
Table 6. Key Players of Portal Vein Embolization
Table 7. Global Metastatic Colorectal Cancer Surgery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Metastatic Colorectal Cancer Surgery Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Metastatic Colorectal Cancer Surgery Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Metastatic Colorectal Cancer Surgery Market Share by Regions (2015-2020)
Table 11. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Metastatic Colorectal Cancer Surgery Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Metastatic Colorectal Cancer Surgery Market Growth Strategy
Table 17. Main Points Interviewed from Key Metastatic Colorectal Cancer Surgery Players
Table 18. Global Metastatic Colorectal Cancer Surgery Revenue by Players (2015-2020) (Million US$)
Table 19. Global Metastatic Colorectal Cancer Surgery Market Share by Players (2015-2020)
Table 20. Global Top Metastatic Colorectal Cancer Surgery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2019)
Table 21. Global Metastatic Colorectal Cancer Surgery by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Metastatic Colorectal Cancer Surgery Product Solution and Service
Table 24. Date of Enter into Metastatic Colorectal Cancer Surgery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020) (Million US$)
Table 27. Global Metastatic Colorectal Cancer Surgery Market Size Share by Type (2015-2020)
Table 28. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Type (2021-2026)
Table 29. Global Metastatic Colorectal Cancer Surgery Market Size Share by Application (2015-2020)
Table 30. Global Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020) (Million US$)
Table 31. Global Metastatic Colorectal Cancer Surgery Market Size Share by Application (2021-2026)
Table 32. North America Key Players Metastatic Colorectal Cancer Surgery Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Metastatic Colorectal Cancer Surgery Market Share (2019-2020)
Table 34. North America Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020) (Million US$)
Table 35. North America Metastatic Colorectal Cancer Surgery Market Share by Type (2015-2020)
Table 36. North America Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020) (Million US$)
Table 37. North America Metastatic Colorectal Cancer Surgery Market Share by Application (2015-2020)
Table 38. Europe Key Players Metastatic Colorectal Cancer Surgery Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Metastatic Colorectal Cancer Surgery Market Share (2019-2020)
Table 40. Europe Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Metastatic Colorectal Cancer Surgery Market Share by Type (2015-2020)
Table 42. Europe Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Metastatic Colorectal Cancer Surgery Market Share by Application (2015-2020)
Table 44. China Key Players Metastatic Colorectal Cancer Surgery Revenue (2019-2020) (Million US$)
Table 45. China Key Players Metastatic Colorectal Cancer Surgery Market Share (2019-2020)
Table 46. China Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020) (Million US$)
Table 47. China Metastatic Colorectal Cancer Surgery Market Share by Type (2015-2020)
Table 48. China Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020) (Million US$)
Table 49. China Metastatic Colorectal Cancer Surgery Market Share by Application (2015-2020)
Table 50. Japan Key Players Metastatic Colorectal Cancer Surgery Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Metastatic Colorectal Cancer Surgery Market Share (2019-2020)
Table 52. Japan Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Metastatic Colorectal Cancer Surgery Market Share by Type (2015-2020)
Table 54. Japan Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Metastatic Colorectal Cancer Surgery Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Metastatic Colorectal Cancer Surgery Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Metastatic Colorectal Cancer Surgery Market Share (2019-2020)
Table 58. Southeast Asia Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Metastatic Colorectal Cancer Surgery Market Share by Type (2015-2020)
Table 60. Southeast Asia Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Metastatic Colorectal Cancer Surgery Market Share by Application (2015-2020)
Table 62. India Key Players Metastatic Colorectal Cancer Surgery Revenue (2019-2020) (Million US$)
Table 63. India Key Players Metastatic Colorectal Cancer Surgery Market Share (2019-2020)
Table 64. India Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020) (Million US$)
Table 65. India Metastatic Colorectal Cancer Surgery Market Share by Type (2015-2020)
Table 66. India Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020) (Million US$)
Table 67. India Metastatic Colorectal Cancer Surgery Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Metastatic Colorectal Cancer Surgery Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Metastatic Colorectal Cancer Surgery Market Share (2019-2020)
Table 70. Central & South America Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Metastatic Colorectal Cancer Surgery Market Share by Type (2015-2020)
Table 72. Central & South America Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Metastatic Colorectal Cancer Surgery Market Share by Application (2015-2020)
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Product
Table 77. Sanofi Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 78. Sanofi Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Eli Lilly Company Details
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Product
Table 87. Eli Lilly Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 88. Eli Lilly Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Product
Table 97. Novartis Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 98. Novartis Recent Development
Table 99. Amgen Company Details
Table 100. Amgen Business Overview
Table 101. Amgen Product
Table 102. Amgen Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 103. Amgen Recent Development
Table 104. Taiho Oncology Company Details
Table 105. Taiho Oncology Business Overview
Table 106. Taiho Oncology Product
Table 107. Taiho Oncology Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 108. Taiho Oncology Recent Development
Table 109. Genentech Business Overview
Table 110. Genentech Product
Table 111. Genentech Company Details
Table 112. Genentech Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 113. Genentech Recent Development
Table 114. EMD Serono Company Details
Table 115. EMD Serono Business Overview
Table 116. EMD Serono Product
Table 117. EMD Serono Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 118. EMD Serono Recent Development
Table 119. Suzhou Zelgen Biopharmaceuticals Company Details
Table 120. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 121. Suzhou Zelgen Biopharmaceuticals Product
Table 122. Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020) (Million US$)
Table 123. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Colorectal Cancer Surgery Market Share by Type: 2020 VS 2026
Figure 2. Tumor Resection Features
Figure 3. Portal Vein Embolization Features
Figure 4. Global Metastatic Colorectal Cancer Surgery Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Cancer Research Centers Case Studies
Figure 8. Metastatic Colorectal Cancer Surgery Report Years Considered
Figure 9. Global Metastatic Colorectal Cancer Surgery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Metastatic Colorectal Cancer Surgery Market Share by Regions: 2020 VS 2026
Figure 11. Global Metastatic Colorectal Cancer Surgery Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Metastatic Colorectal Cancer Surgery Market Share by Players in 2019
Figure 14. Global Top Metastatic Colorectal Cancer Surgery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Surgery Revenue in 2019
Figure 16. North America Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
転移性がん治療の世界市場（～2026年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…- 肛門癌・結腸直腸癌の世界市場（～2026年） Colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in anus in case of anal cancer. Rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has been the major factor driving the market …
- 転移性膵臓がん治療の世界市場（～2026年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…
- 大腸がんの世界市場（～2026年） Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of …
- 大腸がん診断・治療の世界市場（～2026年） Colorectal cancer is the development of cancer from the colonor rectum. The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer. Market Analysis and Insights: Global C…